Is It Time for Ocrelizumab Extended Interval Dosing in Relapsing Remitting MS? Evidence from An Italian Multicenter Experience During the COVID-19 Pandemic
Article in Neurotherapeutics (August 2022)
The most recent citing publications are shown below. View all 2 publications that cite this research output on Dimensions.
Article in Neurotherapeutics (August 2022)
Article in Frontiers in Neurology (December 2021)